CNS Pharmaceuticals, Inc. (CNSP) › Total LiabilitiesCNS Pharmaceuticals, Inc. (CNSP) — Total LiabilitiesAnnual figures by period end, from SEC filings.2018-12-31: $1.23M2019-12-31: $311.0K2020-12-31: $1.91M2021-12-31: $2.59M2022-12-31: $4.92M2023-12-31: $6.13M2024-12-31: $2.52M2025-12-31: $4.10M$4.10M2018-12-31Total Liabilities (USD)2025-12-31Period endedTotal LiabilitiesChange YoYSource filing2025-12-31$4.10M+62.5%2026-03-31Balance as of period end2024-12-31$2.52M-58.8%2026-03-31Balance as of period end2023-12-31$6.13M+24.6%2025-03-31Balance as of period end2022-12-31$4.92M+89.7%2024-04-01Balance as of period end2021-12-31$2.59M+36.1%2023-03-31Balance as of period end2020-12-31$1.91M+512.7%2022-03-03Balance as of period end2019-12-31$311.0K-74.8%2021-02-12Balance as of period end2018-12-31$1.23M—2020-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)